Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hmga1
|
ENSMUSG00000046711.9 | high mobility group AT-hook 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_27559513_27559664 | Hmga1 | 2893 | 0.105584 | -0.55 | 1.5e-05 | Click! |
chr17_27557770_27557950 | Hmga1 | 1165 | 0.221622 | -0.46 | 4.1e-04 | Click! |
chr17_27555089_27556137 | Hmga1 | 884 | 0.265721 | -0.44 | 7.4e-04 | Click! |
chr17_27556307_27556697 | Hmga1 | 5 | 0.488321 | -0.33 | 1.5e-02 | Click! |
chr17_27556765_27557676 | Hmga1 | 525 | 0.430673 | -0.22 | 1.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_23037418_23037876 | 26.03 |
Nol4 |
nucleolar protein 4 |
1009 |
0.7 |
chr2_114046819_114047040 | 20.87 |
Actc1 |
actin, alpha, cardiac muscle 1 |
5958 |
0.17 |
chr7_69276815_69277321 | 18.64 |
Gm44533 |
predicted gene 44533 |
17473 |
0.24 |
chr13_84783122_84783632 | 15.46 |
Gm26913 |
predicted gene, 26913 |
92436 |
0.09 |
chr3_10685256_10685662 | 15.15 |
Gm37831 |
predicted gene, 37831 |
39143 |
0.17 |
chr1_81520769_81521201 | 14.97 |
Gm37210 |
predicted gene, 37210 |
1356 |
0.55 |
chr6_8105963_8106318 | 14.71 |
Col28a1 |
collagen, type XXVIII, alpha 1 |
26392 |
0.21 |
chr7_51816067_51816244 | 14.41 |
Gm45001 |
predicted gene 45001 |
34149 |
0.12 |
chr6_100733006_100733157 | 13.41 |
Gm15576 |
predicted gene 15576 |
6847 |
0.18 |
chr12_72239575_72239754 | 12.86 |
Rtn1 |
reticulon 1 |
2940 |
0.3 |
chr16_24509582_24509735 | 12.51 |
Morf4l1-ps1 |
mortality factor 4 like 1, pseudogene 1 |
19736 |
0.22 |
chr4_82099688_82099959 | 11.93 |
Gm5860 |
predicted gene 5860 |
33866 |
0.16 |
chr1_98274376_98274527 | 11.83 |
Gm29462 |
predicted gene 29462 |
7300 |
0.22 |
chr18_5022996_5023147 | 11.70 |
Svil |
supervillin |
12095 |
0.29 |
chr4_82690701_82691000 | 11.54 |
Gm11269 |
predicted gene 11269 |
1955 |
0.35 |
chr1_66320866_66321435 | 11.39 |
Map2 |
microtubule-associated protein 2 |
569 |
0.75 |
chr4_32189105_32189411 | 10.96 |
Gm11929 |
predicted gene 11929 |
17890 |
0.19 |
chr2_33593309_33593623 | 10.84 |
Gm38011 |
predicted gene, 38011 |
20932 |
0.15 |
chr10_78727029_78727441 | 10.78 |
Casp14 |
caspase 14 |
8941 |
0.11 |
chr14_120830371_120830865 | 10.78 |
Gm9391 |
predicted gene 9391 |
3460 |
0.2 |
chr8_6456893_6457222 | 10.52 |
Gm44844 |
predicted gene 44844 |
19313 |
0.29 |
chr4_14534902_14535150 | 10.44 |
Slc26a7 |
solute carrier family 26, member 7 |
18657 |
0.26 |
chr18_13678237_13678562 | 10.27 |
AC103362.1 |
novel transcript |
76999 |
0.12 |
chr10_86425574_86426115 | 10.17 |
Syn3 |
synapsin III |
66053 |
0.08 |
chr2_43324048_43324221 | 10.06 |
Gm13464 |
predicted gene 13464 |
195264 |
0.03 |
chr4_71131009_71131663 | 10.02 |
Gm11228 |
predicted gene 11228 |
203 |
0.96 |
chr12_107952275_107952669 | 9.96 |
Bcl11b |
B cell leukemia/lymphoma 11B |
50942 |
0.16 |
chr7_31127074_31128340 | 9.90 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr9_13693996_13694212 | 9.90 |
Maml2 |
mastermind like transcriptional coactivator 2 |
31644 |
0.14 |
chr16_5431046_5431213 | 9.80 |
n-R5s30 |
nuclear encoded rRNA 5S 30 |
106972 |
0.06 |
chr1_97788601_97788883 | 9.80 |
Gin1 |
gypsy retrotransposon integrase 1 |
11343 |
0.18 |
chr1_96346717_96347057 | 9.77 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr10_43023446_43023814 | 9.69 |
Gm47815 |
predicted gene, 47815 |
11363 |
0.22 |
chr13_24565549_24566352 | 9.65 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
16239 |
0.18 |
chr14_102859377_102859572 | 9.53 |
Gm34589 |
predicted gene, 34589 |
24716 |
0.2 |
chr5_90065925_90066243 | 9.52 |
Eif5al3-ps |
eukaryotic translation initiation factor 5A-like 3, pseudogene |
66145 |
0.13 |
chr11_109903301_109903462 | 9.46 |
Gm11697 |
predicted gene 11697 |
32935 |
0.16 |
chr5_78993374_78993615 | 9.39 |
Gm25756 |
predicted gene, 25756 |
213635 |
0.02 |
chr4_75965884_75966035 | 9.34 |
Gm11241 |
predicted gene 11241 |
62804 |
0.14 |
chr1_111833741_111833937 | 9.32 |
Gm37934 |
predicted gene, 37934 |
16 |
0.98 |
chr8_90069471_90069806 | 9.32 |
Tox3 |
TOX high mobility group box family member 3 |
278488 |
0.01 |
chr2_26594675_26595827 | 9.31 |
Egfl7 |
EGF-like domain 7 |
3104 |
0.11 |
chr19_20923632_20923852 | 9.20 |
Gm32750 |
predicted gene, 32750 |
1350 |
0.52 |
chr9_99112541_99112867 | 9.19 |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
27221 |
0.15 |
chr11_5165429_5165927 | 9.12 |
Emid1 |
EMI domain containing 1 |
13421 |
0.16 |
chr13_41729696_41729998 | 9.09 |
Adtrp |
androgen dependent TFPI regulating protein |
70719 |
0.08 |
chr17_10378506_10378798 | 9.09 |
1700110C19Rik |
RIKEN cDNA 1700110C19 gene |
54050 |
0.13 |
chr16_71497162_71497313 | 8.99 |
Gm22797 |
predicted gene, 22797 |
166551 |
0.04 |
chr16_34228583_34229181 | 8.92 |
Kalrn |
kalirin, RhoGEF kinase |
23433 |
0.27 |
chr3_107536889_107537478 | 8.86 |
Ubl4b |
ubiquitin-like 4B |
17890 |
0.15 |
chr10_58855225_58855442 | 8.84 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
41274 |
0.14 |
chr14_18263253_18263404 | 8.83 |
Rpl15 |
ribosomal protein L15 |
6791 |
0.15 |
chr2_41470719_41470900 | 8.83 |
Lrp1b |
low density lipoprotein-related protein 1B |
318269 |
0.01 |
chr16_44687184_44688343 | 8.77 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr18_54452393_54453295 | 8.71 |
Gm50361 |
predicted gene, 50361 |
23921 |
0.19 |
chr17_13654565_13655321 | 8.70 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr18_51984356_51984517 | 8.69 |
Gm50446 |
predicted gene, 50446 |
56885 |
0.14 |
chr15_25754647_25755340 | 8.68 |
Myo10 |
myosin X |
2014 |
0.38 |
chr19_33326930_33327081 | 8.65 |
Rnls |
renalase, FAD-dependent amine oxidase |
65260 |
0.11 |
chr1_137838327_137838702 | 8.65 |
Gm37293 |
predicted gene, 37293 |
26665 |
0.12 |
chr1_30701244_30701419 | 8.64 |
Gm9898 |
predicted gene 9898 |
18631 |
0.22 |
chr10_112572699_112572878 | 8.62 |
Kcnc2 |
potassium voltage gated channel, Shaw-related subfamily, member 2 |
116445 |
0.06 |
chr16_62407712_62407863 | 8.61 |
CT010569.1 |
NADH dehydrogenase 5, mitochondrial (mt-Nd5) pseudogene |
76162 |
0.12 |
chr17_68591618_68591769 | 8.57 |
Gm17921 |
predicted gene, 17921 |
107218 |
0.07 |
chr6_24397466_24397684 | 8.51 |
Iqub |
IQ motif and ubiquitin domain containing |
117492 |
0.05 |
chr6_16314633_16314788 | 8.41 |
Gm3148 |
predicted gene 3148 |
77083 |
0.1 |
chr9_16282506_16282657 | 8.40 |
Fat3 |
FAT atypical cadherin 3 |
95650 |
0.09 |
chr13_6178613_6178764 | 8.38 |
Gm47549 |
predicted gene, 47549 |
90420 |
0.08 |
chr10_26078964_26079158 | 8.37 |
Tmem200a |
transmembrane protein 200A |
9 |
0.95 |
chr12_35896011_35896516 | 8.33 |
Agr3 |
anterior gradient 3 |
29357 |
0.17 |
chr9_114528016_114528485 | 8.29 |
C130032M10Rik |
RIKEN cDNA C130032M10 gene |
12553 |
0.16 |
chr16_87261581_87261944 | 8.22 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
92423 |
0.08 |
chr2_108691713_108692000 | 8.17 |
Gm13914 |
predicted gene 13914 |
42346 |
0.19 |
chr1_14108426_14108817 | 8.16 |
Gm37400 |
predicted gene, 37400 |
4198 |
0.31 |
chr17_81738359_81738776 | 8.13 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
190 |
0.97 |
chr2_40983065_40983216 | 8.11 |
Gm13460 |
predicted gene 13460 |
15717 |
0.24 |
chr10_3417310_3417750 | 8.04 |
Gm24482 |
predicted gene, 24482 |
7493 |
0.25 |
chr16_94721521_94722246 | 8.03 |
Gm41505 |
predicted gene, 41505 |
11 |
0.98 |
chr18_49117752_49118229 | 7.97 |
Gm18993 |
predicted gene, 18993 |
54566 |
0.18 |
chr5_90987721_90988058 | 7.96 |
Epgn |
epithelial mitogen |
39575 |
0.11 |
chr10_8228058_8228339 | 7.95 |
Gm30906 |
predicted gene, 30906 |
52067 |
0.15 |
chr8_45734198_45734373 | 7.90 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
8896 |
0.2 |
chr5_119836588_119836964 | 7.89 |
Tbx5 |
T-box 5 |
621 |
0.7 |
chr3_17319141_17319707 | 7.87 |
Gm30340 |
predicted gene, 30340 |
15001 |
0.21 |
chr13_111235494_111235684 | 7.85 |
3110015C05Rik |
RIKEN cDNA 3110015C05 gene |
6158 |
0.23 |
chr9_75683708_75684585 | 7.83 |
Scg3 |
secretogranin III |
90 |
0.96 |
chr2_134003194_134003360 | 7.77 |
Gm25258 |
predicted gene, 25258 |
418856 |
0.01 |
chr9_10269175_10269351 | 7.76 |
Gm24496 |
predicted gene, 24496 |
21324 |
0.22 |
chr3_50185958_50186323 | 7.67 |
Gm37692 |
predicted gene, 37692 |
19248 |
0.24 |
chr2_93187957_93189155 | 7.62 |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
635 |
0.76 |
chr12_34529306_34529457 | 7.60 |
Hdac9 |
histone deacetylase 9 |
507 |
0.88 |
chr3_159885897_159886109 | 7.60 |
Gm43307 |
predicted gene 43307 |
10157 |
0.23 |
chr18_16561680_16561845 | 7.54 |
Cdh2 |
cadherin 2 |
108307 |
0.07 |
chr2_70908656_70908937 | 7.50 |
Gm13632 |
predicted gene 13632 |
30967 |
0.17 |
chr5_13470497_13470849 | 7.50 |
Gm43130 |
predicted gene 43130 |
10355 |
0.22 |
chr15_37135024_37136161 | 7.49 |
Gm9509 |
predicted gene 9509 |
36812 |
0.14 |
chr4_65958951_65959102 | 7.49 |
Trim32 |
tripartite motif-containing 32 |
353777 |
0.01 |
chr2_85425995_85426146 | 7.46 |
Olfr994 |
olfactory receptor 994 |
4757 |
0.1 |
chr13_83603637_83603851 | 7.45 |
Mef2c |
myocyte enhancer factor 2C |
21859 |
0.22 |
chr5_16778734_16778928 | 7.42 |
Gm28710 |
predicted gene 28710 |
12979 |
0.25 |
chr7_75118068_75118601 | 7.40 |
Sv2b |
synaptic vesicle glycoprotein 2 b |
29392 |
0.22 |
chr3_49757757_49757973 | 7.40 |
Pcdh18 |
protocadherin 18 |
540 |
0.8 |
chr4_25408403_25408554 | 7.37 |
Gm11894 |
predicted gene 11894 |
10871 |
0.22 |
chr2_101600953_101601104 | 7.36 |
B230118H07Rik |
RIKEN cDNA B230118H07 gene |
9528 |
0.18 |
chr4_82555938_82556285 | 7.36 |
Gm11267 |
predicted gene 11267 |
31208 |
0.16 |
chr12_93677590_93677741 | 7.34 |
Gm21007 |
predicted gene, 21007 |
38755 |
0.2 |
chr18_49217789_49217940 | 7.33 |
Gm50231 |
predicted gene, 50231 |
110391 |
0.07 |
chr9_117192209_117192484 | 7.33 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
59251 |
0.13 |
chr9_49570435_49570586 | 7.33 |
Ncam1 |
neural cell adhesion molecule 1 |
1961 |
0.41 |
chr14_120578458_120578609 | 7.31 |
Gm49008 |
predicted gene, 49008 |
54429 |
0.14 |
chr5_15006418_15007243 | 7.31 |
Gm17019 |
predicted gene 17019 |
26168 |
0.18 |
chr14_64589182_64589588 | 7.29 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
310 |
0.8 |
chr15_24567016_24567356 | 7.25 |
Gm48920 |
predicted gene, 48920 |
38292 |
0.19 |
chr9_118255960_118256455 | 7.22 |
Gm17399 |
predicted gene, 17399 |
105976 |
0.06 |
chr13_85311007_85311294 | 7.20 |
Rasa1 |
RAS p21 protein activator 1 |
22020 |
0.23 |
chr10_38357630_38357792 | 7.20 |
Gm48197 |
predicted gene, 48197 |
43865 |
0.17 |
chr11_103763504_103763708 | 7.18 |
Wnt3 |
wingless-type MMTV integration site family, member 3 |
10544 |
0.15 |
chr15_85993884_85994294 | 7.17 |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
15359 |
0.2 |
chrX_59243284_59243435 | 7.16 |
Gm14890 |
predicted gene 14890 |
46396 |
0.15 |
chr10_11515311_11515489 | 7.15 |
Gm48679 |
predicted gene, 48679 |
10104 |
0.23 |
chr16_90845132_90845300 | 7.12 |
Eva1c |
eva-1 homolog C (C. elegans) |
1182 |
0.38 |
chr15_95526740_95526917 | 7.12 |
Nell2 |
NEL-like 2 |
1350 |
0.54 |
chr16_67871421_67871572 | 7.11 |
Gm49648 |
predicted gene, 49648 |
130379 |
0.05 |
chr17_70630209_70630431 | 7.11 |
Dlgap1 |
DLG associated protein 1 |
68768 |
0.11 |
chr1_18758436_18758855 | 7.09 |
Gm5252 |
predicted gene 5252 |
50217 |
0.18 |
chr2_76970230_76970535 | 7.06 |
Ttn |
titin |
9800 |
0.25 |
chr9_98428823_98429179 | 7.06 |
Rbp1 |
retinol binding protein 1, cellular |
6040 |
0.22 |
chr6_4740407_4740752 | 7.03 |
Sgce |
sarcoglycan, epsilon |
372 |
0.84 |
chr10_101373884_101374182 | 7.02 |
Gm19233 |
predicted gene, 19233 |
102412 |
0.08 |
chr8_109417176_109417525 | 7.01 |
Gm23163 |
predicted gene, 23163 |
8394 |
0.23 |
chr3_5388657_5389390 | 7.01 |
4930555M17Rik |
RIKEN cDNA 4930555M17 gene |
126310 |
0.05 |
chr8_34890619_34890939 | 6.97 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
628 |
0.77 |
chr2_60722962_60723113 | 6.96 |
Itgb6 |
integrin beta 6 |
394 |
0.89 |
chr12_41308865_41309016 | 6.95 |
Gm47376 |
predicted gene, 47376 |
39150 |
0.15 |
chr6_5992467_5992847 | 6.93 |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
13409 |
0.22 |
chr7_80655496_80655692 | 6.93 |
Gm15880 |
predicted gene 15880 |
19577 |
0.15 |
chr9_77340219_77340422 | 6.92 |
Mlip |
muscular LMNA-interacting protein |
307 |
0.88 |
chr5_122950982_122952145 | 6.92 |
Kdm2b |
lysine (K)-specific demethylase 2B |
427 |
0.77 |
chr8_61309392_61309892 | 6.92 |
1700001D01Rik |
RIKEN cDNA 1700001D01 gene |
20770 |
0.18 |
chr12_16391867_16392199 | 6.92 |
Gm48605 |
predicted gene, 48605 |
159806 |
0.03 |
chr8_93569756_93570135 | 6.92 |
Gm45708 |
predicted gene 45708 |
5498 |
0.21 |
chr6_22984216_22984575 | 6.91 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
1914 |
0.44 |
chr12_3834339_3834973 | 6.90 |
Dnmt3a |
DNA methyltransferase 3A |
14979 |
0.17 |
chr16_94827069_94827617 | 6.89 |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
29329 |
0.18 |
chr5_122100700_122101295 | 6.89 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
14 |
0.97 |
chr18_25678184_25678915 | 6.83 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chr7_112225900_112226458 | 6.82 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
289 |
0.94 |
chr3_5347552_5347820 | 6.82 |
Zfhx4 |
zinc finger homeodomain 4 |
106014 |
0.07 |
chr9_110053315_110053992 | 6.81 |
Map4 |
microtubule-associated protein 4 |
1601 |
0.28 |
chr4_81566140_81566319 | 6.80 |
Gm11765 |
predicted gene 11765 |
104497 |
0.07 |
chr1_30061154_30061322 | 6.79 |
Gm23771 |
predicted gene, 23771 |
75304 |
0.12 |
chr9_41593811_41594013 | 6.78 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
5418 |
0.12 |
chr1_81594178_81594459 | 6.78 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr3_89226358_89226776 | 6.77 |
Thbs3 |
thrombospondin 3 |
317 |
0.45 |
chr16_37963771_37963952 | 6.77 |
Gm25140 |
predicted gene, 25140 |
16226 |
0.18 |
chr16_43503682_43504014 | 6.76 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
151 |
0.97 |
chr4_82532408_82532766 | 6.74 |
Gm11266 |
predicted gene 11266 |
24571 |
0.17 |
chr15_41082521_41082910 | 6.74 |
Gm49524 |
predicted gene, 49524 |
84755 |
0.09 |
chr5_53123649_53123869 | 6.74 |
n-R5s171 |
nuclear encoded rRNA 5S 171 |
19401 |
0.17 |
chr4_117549884_117550465 | 6.69 |
Eri3 |
exoribonuclease 3 |
191 |
0.93 |
chr16_39453494_39453645 | 6.68 |
Gm24795 |
predicted gene, 24795 |
1446 |
0.49 |
chr17_55367602_55367789 | 6.66 |
Gm49921 |
predicted gene, 49921 |
21012 |
0.2 |
chr5_70842284_70842796 | 6.64 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
77 |
0.99 |
chr1_24005288_24006003 | 6.64 |
Sdhaf4 |
succinate dehydrogenase complex assembly factor 4 |
11 |
0.64 |
chr13_28415819_28416047 | 6.64 |
Gm40841 |
predicted gene, 40841 |
3930 |
0.29 |
chr9_41375999_41376652 | 6.63 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
4 |
0.98 |
chr1_11268335_11268486 | 6.63 |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 |
4447 |
0.27 |
chr1_85089758_85090158 | 6.62 |
Gm10553 |
predicted gene 10553 |
9554 |
0.09 |
chr10_56980781_56980956 | 6.62 |
Gm36827 |
predicted gene, 36827 |
1364 |
0.54 |
chr19_26770137_26770516 | 6.62 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
165 |
0.96 |
chr1_63819909_63820082 | 6.59 |
Gm13751 |
predicted gene 13751 |
25583 |
0.16 |
chr16_43309736_43309918 | 6.58 |
Gm37946 |
predicted gene, 37946 |
1546 |
0.36 |
chr12_12220796_12221120 | 6.55 |
Fam49a |
family with sequence similarity 49, member A |
41181 |
0.19 |
chrX_77148145_77148296 | 6.54 |
Gm5398 |
predicted gene 5398 |
142595 |
0.04 |
chr15_33687985_33688178 | 6.53 |
Tspyl5 |
testis-specific protein, Y-encoded-like 5 |
197 |
0.95 |
chr5_44698439_44698590 | 6.51 |
Gm3364 |
predicted gene 3364 |
8376 |
0.14 |
chr16_33605736_33606716 | 6.50 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr9_61277943_61278135 | 6.48 |
B930092H01Rik |
RIKEN cDNA B930092H01 gene |
15770 |
0.2 |
chr13_83714747_83715651 | 6.47 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6182 |
0.14 |
chr13_29565628_29566161 | 6.47 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
48440 |
0.19 |
chr16_50732699_50733248 | 6.46 |
Dubr |
Dppa2 upstream binding RNA |
200 |
0.94 |
chr13_38410275_38410887 | 6.46 |
Bmp6 |
bone morphogenetic protein 6 |
16136 |
0.17 |
chr10_127530765_127530934 | 6.46 |
Nxph4 |
neurexophilin 4 |
3710 |
0.12 |
chr3_119498899_119499105 | 6.44 |
Gm23432 |
predicted gene, 23432 |
139872 |
0.05 |
chr2_138256185_138257474 | 6.44 |
Btbd3 |
BTB (POZ) domain containing 3 |
159 |
0.98 |
chr8_3499866_3501209 | 6.43 |
Mcoln1 |
mucolipin 1 |
3 |
0.96 |
chr13_36293458_36293811 | 6.42 |
Fars2 |
phenylalanine-tRNA synthetase 2 (mitochondrial) |
33324 |
0.16 |
chr2_146764294_146764805 | 6.40 |
Gm14111 |
predicted gene 14111 |
8844 |
0.26 |
chr13_30782030_30782219 | 6.40 |
Gm29675 |
predicted gene, 29675 |
13102 |
0.19 |
chr10_14017823_14018282 | 6.40 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
51028 |
0.13 |
chr5_103497567_103497760 | 6.39 |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
31903 |
0.15 |
chr12_12287814_12287996 | 6.39 |
Fam49a |
family with sequence similarity 49, member A |
25716 |
0.24 |
chr13_84344282_84344641 | 6.38 |
Gm26927 |
predicted gene, 26927 |
4348 |
0.26 |
chr1_42693070_42693237 | 6.38 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
0 |
0.96 |
chr13_51778976_51779261 | 6.37 |
Sema4d |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
2007 |
0.34 |
chr14_101352726_101352900 | 6.33 |
Hspd1-ps5 |
heat shock protein 1 (chaperonin), pseudogene 5 |
9269 |
0.26 |
chr4_23982818_23983489 | 6.30 |
Gm28448 |
predicted gene 28448 |
49199 |
0.19 |
chr17_44230130_44230445 | 6.29 |
Clic5 |
chloride intracellular channel 5 |
6819 |
0.3 |
chr12_12401122_12401348 | 6.29 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
8620 |
0.3 |
chr4_74012844_74013017 | 6.27 |
Frmd3 |
FERM domain containing 3 |
512 |
0.8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.8 | 11.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
3.8 | 7.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
3.6 | 10.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
3.5 | 17.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
3.5 | 10.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.3 | 9.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
3.3 | 3.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
3.2 | 9.6 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
3.2 | 22.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.9 | 11.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.7 | 10.8 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.6 | 15.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.6 | 10.5 | GO:0001927 | exocyst assembly(GO:0001927) |
2.6 | 5.2 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
2.6 | 10.3 | GO:0007412 | axon target recognition(GO:0007412) |
2.5 | 5.0 | GO:0070384 | Harderian gland development(GO:0070384) |
2.4 | 7.1 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
2.4 | 11.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.3 | 11.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
2.2 | 6.6 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.2 | 6.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.2 | 8.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.1 | 6.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
2.1 | 4.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
2.1 | 12.5 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.1 | 8.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.1 | 6.2 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
2.0 | 4.1 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
2.0 | 8.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
2.0 | 6.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.0 | 5.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
2.0 | 5.9 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
2.0 | 5.9 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.9 | 5.8 | GO:0021564 | vagus nerve development(GO:0021564) |
1.9 | 5.8 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.9 | 3.9 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
1.9 | 7.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.9 | 5.7 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
1.8 | 7.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.8 | 3.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.8 | 5.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.8 | 14.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.7 | 8.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.7 | 5.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
1.7 | 5.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.6 | 1.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.6 | 1.6 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.6 | 4.8 | GO:0060437 | lung growth(GO:0060437) |
1.6 | 3.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.6 | 4.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.6 | 6.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.5 | 4.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.5 | 6.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.5 | 4.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.5 | 7.6 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.5 | 4.5 | GO:0030070 | insulin processing(GO:0030070) |
1.5 | 4.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.5 | 9.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.5 | 3.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.5 | 4.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.5 | 4.5 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.5 | 4.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.5 | 4.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.4 | 4.3 | GO:0060174 | limb bud formation(GO:0060174) |
1.4 | 4.3 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.4 | 8.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.4 | 1.4 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
1.4 | 2.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.4 | 4.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.4 | 6.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.4 | 4.1 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.3 | 2.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.3 | 5.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.3 | 2.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.3 | 1.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.3 | 3.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.3 | 6.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
1.3 | 6.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.3 | 5.2 | GO:0046959 | habituation(GO:0046959) |
1.3 | 3.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.3 | 6.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.3 | 2.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.3 | 3.8 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.3 | 5.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.3 | 3.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.3 | 1.3 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.3 | 3.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.3 | 5.0 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.2 | 3.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.2 | 4.9 | GO:0070842 | aggresome assembly(GO:0070842) |
1.2 | 3.7 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.2 | 2.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.2 | 7.1 | GO:0060513 | prostatic bud formation(GO:0060513) |
1.2 | 4.7 | GO:0030091 | protein repair(GO:0030091) |
1.2 | 8.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.2 | 2.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 1.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.2 | 4.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.2 | 3.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.2 | 3.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.2 | 1.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.2 | 3.5 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.1 | 2.3 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.1 | 19.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.1 | 6.8 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
1.1 | 3.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.1 | 3.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.1 | 4.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.1 | 3.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.1 | 1.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.1 | 5.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.1 | 3.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.1 | 6.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.1 | 1.1 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
1.1 | 6.6 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
1.1 | 1.1 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
1.1 | 5.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.1 | 2.2 | GO:2000064 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.1 | 5.4 | GO:0015808 | L-alanine transport(GO:0015808) |
1.1 | 5.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.0 | 2.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.0 | 4.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.0 | 2.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
1.0 | 9.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.0 | 2.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.0 | 2.1 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
1.0 | 2.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.0 | 2.0 | GO:0090135 | actin filament branching(GO:0090135) |
1.0 | 4.1 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
1.0 | 1.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.0 | 3.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.0 | 3.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.0 | 2.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.0 | 2.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.0 | 1.0 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
1.0 | 6.9 | GO:0048664 | neuron fate determination(GO:0048664) |
1.0 | 7.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.0 | 1.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.0 | 4.8 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.0 | 8.7 | GO:0060013 | righting reflex(GO:0060013) |
0.9 | 0.9 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.9 | 2.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.9 | 2.8 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.9 | 2.7 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.9 | 4.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.9 | 2.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.9 | 6.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.9 | 6.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.9 | 3.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.9 | 14.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.9 | 1.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.9 | 4.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.9 | 2.6 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) asymmetric neuroblast division(GO:0055059) |
0.9 | 6.1 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.9 | 4.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.9 | 3.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.9 | 0.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.9 | 2.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.8 | 3.4 | GO:0022038 | corpus callosum development(GO:0022038) |
0.8 | 5.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.8 | 2.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.8 | 4.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.8 | 2.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.8 | 4.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.8 | 2.4 | GO:0032439 | endosome localization(GO:0032439) |
0.8 | 1.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.8 | 2.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 0.8 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.8 | 2.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.8 | 1.6 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.8 | 1.6 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.8 | 0.8 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.8 | 0.8 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.8 | 1.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.8 | 3.9 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 3.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.8 | 2.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.8 | 2.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.8 | 4.6 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.8 | 3.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.8 | 3.0 | GO:0061055 | myotome development(GO:0061055) |
0.8 | 3.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.8 | 3.8 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.8 | 12.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 2.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.7 | 0.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.7 | 0.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.7 | 6.6 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.7 | 3.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 1.4 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.7 | 2.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.7 | 1.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.7 | 3.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 0.7 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.7 | 1.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 2.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.7 | 2.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.7 | 1.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.7 | 2.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.7 | 1.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 2.8 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.7 | 0.7 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.7 | 4.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.7 | 6.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.7 | 2.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.7 | 2.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.7 | 2.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.7 | 11.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 4.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.7 | 1.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.7 | 2.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.7 | 9.4 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.7 | 7.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.7 | 0.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.7 | 2.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 4.6 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.7 | 2.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.7 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.7 | 2.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.7 | 0.7 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.7 | 2.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.7 | 0.7 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.6 | 2.6 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.6 | 1.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.6 | 5.2 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.6 | 5.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.6 | 4.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.6 | 3.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.6 | 3.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.6 | 0.6 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 0.6 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.6 | 1.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.6 | 1.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 0.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.6 | 2.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.6 | 2.5 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.6 | 3.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.6 | 1.2 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.6 | 0.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 7.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.6 | 1.8 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.6 | 4.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.6 | 1.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.6 | 4.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.6 | 3.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.6 | 1.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.6 | 1.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 1.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.6 | 4.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.6 | 0.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 3.5 | GO:0060004 | reflex(GO:0060004) |
0.6 | 2.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.6 | 2.9 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.6 | 1.7 | GO:0072017 | distal tubule development(GO:0072017) |
0.6 | 4.6 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.6 | 5.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 0.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 1.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.6 | 1.7 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.6 | 4.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.6 | 1.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.6 | 1.7 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.6 | 2.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.6 | 2.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.6 | 2.8 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.6 | 1.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.6 | 1.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.6 | 1.7 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.5 | 2.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 1.6 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.5 | 1.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 8.1 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.5 | 1.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.5 | 0.5 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.5 | 3.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 0.5 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.5 | 0.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 1.6 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.5 | 2.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 2.6 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.5 | 2.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.5 | 1.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.5 | 1.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 3.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.5 | 1.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.5 | 2.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.5 | 1.5 | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
0.5 | 2.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 2.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.5 | 2.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.5 | 1.5 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.5 | 1.5 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.5 | 1.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.5 | 1.4 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.5 | 1.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.5 | 1.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 21.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 0.5 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.5 | 6.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.5 | 6.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 0.5 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 1.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.5 | 0.5 | GO:0042160 | regulation of lipoprotein oxidation(GO:0034442) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.5 | 0.5 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 1.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.5 | 0.5 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.5 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 2.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 1.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.5 | 1.4 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.5 | 0.9 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.5 | 0.9 | GO:0032202 | telomere assembly(GO:0032202) |
0.5 | 0.9 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 1.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.5 | 0.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.5 | 1.8 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.5 | 1.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 0.9 | GO:0071435 | potassium ion export(GO:0071435) |
0.5 | 0.5 | GO:0070836 | caveola assembly(GO:0070836) |
0.4 | 2.7 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.4 | 4.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.4 | 4.4 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.4 | 1.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 0.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.4 | 1.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 4.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.4 | 1.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 0.9 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.4 | 1.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 3.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 24.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 1.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 1.7 | GO:0031620 | regulation of fever generation(GO:0031620) |
0.4 | 1.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 0.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.4 | 0.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.4 | 1.7 | GO:0006573 | valine metabolic process(GO:0006573) |
0.4 | 0.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.4 | 7.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 0.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.4 | 2.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.4 | 1.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.8 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.4 | 0.4 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.4 | 2.0 | GO:0060045 | positive regulation of cardiac muscle cell proliferation(GO:0060045) |
0.4 | 2.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 1.2 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.4 | 1.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 0.8 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.4 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 2.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.4 | 0.8 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.4 | 0.8 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.4 | 0.8 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 1.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.4 | 2.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 0.4 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 0.8 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 0.8 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.4 | 1.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 0.4 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.4 | 1.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.4 | 1.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 0.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 0.7 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 0.7 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.4 | 1.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.4 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 0.4 | GO:0033122 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.4 | 0.7 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.4 | 1.1 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 2.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 0.4 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.3 | 2.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 1.0 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.3 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 1.4 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.3 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 2.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 1.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 7.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.3 | 3.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.3 | 1.4 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 1.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 1.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.3 | 1.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 0.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.3 | 1.0 | GO:0002001 | renin secretion into blood stream(GO:0002001) |
0.3 | 2.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 1.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 2.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 0.6 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.3 | 0.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.3 | 0.6 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.3 | 2.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.3 | 3.8 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.3 | 0.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 0.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 0.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 2.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 0.6 | GO:0070268 | cornification(GO:0070268) |
0.3 | 2.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 2.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 3.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 3.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.6 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.3 | 2.4 | GO:0001964 | startle response(GO:0001964) |
0.3 | 0.6 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 0.6 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.3 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 0.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.3 | 1.4 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 2.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.3 | 4.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 1.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.3 | 0.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 0.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.3 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 3.0 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.3 | 0.3 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.3 | 0.3 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.3 | 1.6 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 1.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 1.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 0.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 1.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 1.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 0.3 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.3 | 0.5 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 14.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 1.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.8 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 0.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 0.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.7 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 1.2 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 5.8 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.2 | 4.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 1.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.7 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.5 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.2 | 0.7 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 1.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 0.2 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 0.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 1.2 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.5 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.2 | 0.2 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.7 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 0.5 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 | 0.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.5 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.2 | 0.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.2 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.7 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.2 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.7 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 0.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 0.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 3.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.2 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 1.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 1.3 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.2 | 0.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 4.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 4.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 1.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 0.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 1.4 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 1.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 0.4 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 1.0 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.8 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 1.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.2 | 3.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.6 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.6 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.4 | GO:2000589 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 0.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.2 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 4.5 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.7 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 3.0 | GO:0001508 | action potential(GO:0001508) |
0.2 | 0.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.2 | 0.7 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 2.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 0.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.8 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.2 | 0.3 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.2 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 1.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 0.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.3 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.2 | 0.8 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.2 | 0.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.9 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 0.6 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 0.6 | GO:0043371 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) |
0.2 | 1.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 1.9 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 1.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 1.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.3 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 2.2 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 1.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 1.9 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 2.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 2.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 2.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 3.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.6 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.2 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 1.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.2 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.6 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 1.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.1 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 1.3 | GO:0001662 | behavioral fear response(GO:0001662) |
0.1 | 0.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 1.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 1.4 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.2 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.1 | 0.4 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.4 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.6 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 1.4 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
0.1 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.6 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.1 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.2 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.1 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 1.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 1.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.3 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.1 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.1 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.0 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 1.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.0 | 0.1 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.0 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.2 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.1 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.2 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.0 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
0.0 | 0.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.0 | 0.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
4.2 | 12.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
2.7 | 16.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.5 | 15.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
2.5 | 15.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
2.2 | 6.5 | GO:0072534 | perineuronal net(GO:0072534) |
1.7 | 5.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.7 | 5.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.6 | 4.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.6 | 12.8 | GO:0043083 | synaptic cleft(GO:0043083) |
1.6 | 9.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.5 | 1.5 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.4 | 25.6 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.4 | 4.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.4 | 14.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 2.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.3 | 3.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.2 | 16.0 | GO:0005916 | fascia adherens(GO:0005916) |
1.2 | 3.6 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.1 | 5.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.1 | 4.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.0 | 3.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.0 | 6.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.0 | 7.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.0 | 11.7 | GO:0071564 | npBAF complex(GO:0071564) |
1.0 | 1.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.9 | 3.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.9 | 2.6 | GO:0097433 | dense body(GO:0097433) |
0.8 | 3.4 | GO:0044308 | axonal spine(GO:0044308) |
0.8 | 6.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.8 | 10.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.8 | 2.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.8 | 9.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.8 | 3.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 3.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 3.7 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.7 | 2.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.7 | 2.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.7 | 10.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 2.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.7 | 2.2 | GO:0030673 | axolemma(GO:0030673) |
0.7 | 2.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 2.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.7 | 32.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.7 | 2.0 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.7 | 9.2 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 2.4 | GO:0051286 | cell tip(GO:0051286) |
0.6 | 1.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 1.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.6 | 1.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.6 | 4.7 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 4.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.6 | 12.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 1.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 2.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 30.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 5.8 | GO:0043656 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.5 | 15.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 4.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 3.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.5 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 8.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.5 | 7.1 | GO:0043034 | costamere(GO:0043034) |
0.5 | 7.4 | GO:0043205 | fibril(GO:0043205) |
0.5 | 0.9 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 10.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 2.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 2.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 0.9 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 32.1 | GO:0031674 | I band(GO:0031674) |
0.4 | 4.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 3.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 2.9 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 0.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 3.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 6.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 1.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 51.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 5.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 1.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 0.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 1.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 5.0 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 5.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 3.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 2.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 1.0 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 3.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 3.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 1.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 2.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 8.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 24.1 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 0.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 2.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 3.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 3.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 1.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 1.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.2 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 4.2 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 2.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.9 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.1 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 4.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.5 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 1.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 2.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 1.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 24.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 3.6 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.8 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 1.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 25.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 0.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 3.1 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 4.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.5 | GO:0031672 | A band(GO:0031672) |
0.1 | 8.3 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 9.1 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 3.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.3 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 2.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 4.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 11.2 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.5 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.0 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 19.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.2 | 12.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.2 | 9.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.8 | 5.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.7 | 10.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
2.5 | 7.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.4 | 9.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.3 | 9.1 | GO:0031433 | telethonin binding(GO:0031433) |
2.3 | 6.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.2 | 8.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.2 | 10.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.0 | 18.1 | GO:0031432 | titin binding(GO:0031432) |
1.9 | 5.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.8 | 9.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.7 | 6.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.7 | 5.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.7 | 5.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.6 | 11.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.6 | 4.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.6 | 8.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.5 | 6.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.5 | 4.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.5 | 3.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.5 | 4.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.4 | 1.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.4 | 25.8 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.4 | 8.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.3 | 2.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.3 | 6.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.3 | 4.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.3 | 5.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.3 | 11.7 | GO:0038191 | neuropilin binding(GO:0038191) |
1.3 | 6.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.3 | 3.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.2 | 4.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.2 | 6.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.2 | 6.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.2 | 6.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.2 | 8.5 | GO:0003680 | AT DNA binding(GO:0003680) |
1.2 | 23.4 | GO:0003785 | actin monomer binding(GO:0003785) |
1.2 | 5.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.1 | 4.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.1 | 5.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.1 | 3.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.1 | 5.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.1 | 4.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.1 | 4.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.1 | 12.9 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.1 | 3.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.9 | 3.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.9 | 2.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.9 | 3.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 5.8 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.8 | 2.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.8 | 7.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.8 | 3.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 0.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.8 | 3.2 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 3.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.7 | 4.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 2.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.7 | 9.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.7 | 2.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.7 | 0.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 1.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.7 | 2.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.7 | 5.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 2.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.7 | 2.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 2.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 2.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.7 | 3.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.6 | 2.6 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.6 | 5.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.6 | 2.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.6 | 12.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.6 | 2.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 4.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.6 | 2.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.6 | 2.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 6.5 | GO:0005522 | profilin binding(GO:0005522) |
0.6 | 1.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 19.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.6 | 1.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.6 | 4.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.6 | 21.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.6 | 1.7 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.6 | 2.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 3.8 | GO:0018651 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.5 | 1.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.5 | 1.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.5 | 1.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 2.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 7.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.5 | 1.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.5 | 1.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 2.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 4.5 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.5 | 2.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 14.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 2.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.5 | 1.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 9.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 1.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.5 | 0.5 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.5 | 1.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 4.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 1.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 2.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 1.7 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 0.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 1.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 4.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 2.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 4.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 2.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.4 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 5.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 2.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 2.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 2.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 2.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.4 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 0.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 10.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.4 | 2.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 3.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 2.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.4 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 1.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 1.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 2.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.4 | 1.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 3.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.4 | 2.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.4 | 1.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 4.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 1.4 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.3 | 3.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 2.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 1.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 1.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 2.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 5.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 3.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 1.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 0.3 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.3 | 1.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 1.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 4.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 2.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 7.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 0.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 0.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 0.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 1.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 1.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 0.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 3.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 1.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 2.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 2.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 0.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 1.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 1.5 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 2.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 0.8 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 4.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 1.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.3 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 20.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 6.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 2.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 1.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 1.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 1.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 1.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 5.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.2 | 2.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 4.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 1.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 2.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 5.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 3.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 2.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 20.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 2.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 3.3 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 1.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 1.0 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.2 | 0.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 1.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 1.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 2.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 5.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 4.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 0.5 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 1.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 1.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 6.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 1.5 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 1.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 2.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 2.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 1.1 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 2.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.4 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 2.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 3.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 1.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.5 | GO:0034916 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 1.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.4 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 1.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 1.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 17.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 4.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 3.8 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 2.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 2.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 6.3 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.2 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 3.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 23.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 10.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 5.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 2.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 9.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 2.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 2.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.5 | 9.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 16.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.5 | 11.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 16.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 4.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 12.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 1.2 | ST ADRENERGIC | Adrenergic Pathway |
0.4 | 11.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 6.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 4.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 4.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 1.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 4.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 3.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 9.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 1.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 5.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 6.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 2.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 6.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 2.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 9.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 4.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 13.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 4.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 3.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 2.0 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 3.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 4.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 17.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 4.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 3.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.6 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 2.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 17.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 11.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 19.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 18.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.5 | 20.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.2 | 28.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.0 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.9 | 18.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.9 | 19.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.9 | 10.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.9 | 8.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.8 | 8.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.8 | 11.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.8 | 9.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.7 | 18.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.7 | 17.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 7.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.6 | 7.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.6 | 13.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 1.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.6 | 14.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.6 | 9.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 7.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 5.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 0.5 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.5 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.5 | 1.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 22.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 8.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 8.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.5 | 12.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 3.5 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.4 | 13.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 3.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 5.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.4 | 3.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 5.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 2.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 3.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 2.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 4.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 3.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 1.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 0.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 5.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 5.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 8.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 1.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 1.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 3.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 2.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 7.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 2.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 2.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 2.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 0.6 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 1.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 1.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 1.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 1.3 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 0.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 6.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 2.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.5 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.9 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.7 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.3 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 4.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 2.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |